Fluoropyrimidine-induced cardiotoxicity
Open Access
- 24 December 2020
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 11 (12) , 1008-+
Abstract
Cardio-oncology is a discipline based on early screening, monitoring, and treating chemotherapy-induced cardiotoxicity. There are many chemotherapeutics known for their cardiac toxic effects, including fluoropyrimidines. Fluoropyrimidine represents the cornerstone of many types of cancer and each year almost two million cancer patients undergo this treatment. Fluoropyrimidine-induced cardiotoxicity can be manifested in several forms, from angina pectoris to sudden death. This paper is a review of how the cardiotoxicity of fluoropyrimidines is presented, the mechanisms of its occurrence, its diagnosis, and management.Keywords
This publication has 63 references indexed in Scilit:
- Alternative Treatment Options in Colorectal Cancer Patients With 5–Fluorouracil- or Capecitabine-Induced CardiotoxicityClinical Colorectal Cancer, 2013
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2012
- Clinical and Electrocardiography Changes in Patients Treated with CapecitabineChemotherapy, 2011
- Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case reportJournal of Cardiovascular Medicine, 2009
- Fluoropyrimidine-associated cardiotoxicity: revisitedExpert Opinion on Drug Safety, 2009
- Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective studyJournal of Cancer Research and Clinical Oncology, 2007
- Effects of 5-Fluorouracil on Erythrocytes in Relation to Its Cardiotoxicity: Membrane Structure and FunctioningJournal of Chemical Information and Modeling, 2005
- Influence of high-dose leucovorin and 5-fluorouracil chemotherapy regimen on P wave duration and dispersionJournal of Clinical Pharmacy and Therapeutics, 2004
- High Incidence of Angina pectoris in Patients Treated with 5-FluorouracilOncology, 2003
- REDUCED ANTIOXIDANT DEFENSE CAPACITY IN MYOCARDIAL TISSUE FROM GUINEA PIGS TREATED WITH 5-FLUOROURACILJournal of Toxicology and Environmental Health, Part A, 2000